Neuromuscular Manifestations
Neuromuscular Manifestations
Explore linked clinical trials. Standard reference: MESH:M0328296676 results · Page 1 of 28
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study | Apnea, Atrophy, Body Weight, Dyssomnias, Fibrosis, Insulin Resistance, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Sarcopenia, Signs and Symptoms, Sleep Disorders, Intrinsic, cardiovascular disorder, cirrhosis of liver, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, hypertensive disorder, metabolic disease, muscular atrophy, nervous system disorder, nutritional disorder, obesity disorder, obstructive sleep apnea syndrome, overnutrition, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder, type 2 diabetes mellitus, vascular disorder | Enrolling by invitation | Not stated | 2026-10-09 | NCT07312136 | |
| Clinical Trial of CG-BM1 Allogeneic Human Bone Marrow Mesenchymal Stem Cell Injection in the Treatment of Sarcopenia | Atrophy, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, muscular atrophy, nervous system disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-08 | NCT07865676 | |
| Automated and Reliable Estimation of Patient Height From CT Scan Using an Artificial Intelligence Algorithm | Atrophy, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, muscular atrophy, nervous system disorder, nutritional deficiency disease, nutritional disorder | Not yet recruiting | Not stated | 2026-10-08 | NCT07864857 | |
| GLP-1 Receptor Agonist Use and Sarcopenia in Obese Individuals Without Diabetes | Atrophy, Body Weight, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, muscular atrophy, nervous system disorder, nutritional disorder, obesity disorder, overnutrition | Recruiting | Not stated | 2026-10-08 | NCT07858864 | |
| At Home Use of Stimulation Suits for Managing MS Symptoms | Ataxia, Motor, CNS demyelinating autoimmune disease, Dyskinesias, Muscle Hypertonia, Muscle Spasticity, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, atactic disorder, non-human animal, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, central nervous system disorder, cerebellar ataxia, cerebellar disorder, demyelinating disease, immune system disorder, multiple sclerosis, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder | Recruiting | Not applicable | 2026-10-08 | NCT07202195 | |
| Effect of Sarcopenia on the Occurrence of Toxicity Related to Anti-cancer Treatments | Atrophy, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, muscular atrophy, neoplasm, nervous system disorder | Recruiting | Not applicable | 2026-10-08 | NCT06274268 | |
| AI-Based Conversational Social Support for Older Adults With Heart Failure | Atrophy, Frailty, Neurologic Manifestations, Neuromuscular Manifestations, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, cardiovascular disorder, heart disorder, heart failure, muscular atrophy, nervous system disorder | Recruiting | Not applicable | 2026-10-07 | NCT07862933 | |
| Vicia Faba Peptides and Resistance Training in the Elderly | Atrophy, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, muscular atrophy, nervous system disorder | Enrolling by invitation | Not applicable | 2026-10-07 | NCT07858292 | |
| Sarcopenia and Interlaminar Epidural Steroid Injection Outcomes in Lumbar Spinal Stenosis | Atrophy, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, bone disorder, muscular atrophy, musculoskeletal system disorder, nervous system disorder, spinal stenosis, vertebral column disorder | Recruiting | Not stated | 2026-10-07 | NCT07855419 | |
| Swallowing Rehabilitation Program for Head and Neck Tumor Patients | Deglutition Disorders, Digestive System Diseases, Head and Neck Neoplasms, Neoplasms by Site, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Signs and Symptoms, Pharyngeal Diseases, Signs and Symptoms, Spasm, Trismus, digestive system disorder, esophageal disorder, neoplasm, nervous system disorder, otorhinolaryngologic disease | Recruiting | Not applicable | 2026-10-07 | NCT07795294 | |
| Exercise and Nutritional Intervention in Patients With Melanoma Receiving Immunotherapy | Atrophy, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, muscular atrophy, neoplasm, nervous system disorder, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Not yet recruiting | Not applicable | 2026-10-07 | NCT07761871 | |
| Essential Amino Acid Supplementation for Femoral Fragility Fractures | Atrophy, Femoral Fractures, Leg Injuries, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, bone fracture, injury, muscular atrophy, nervous system disorder | Recruiting | Phase 2 | 2026-10-07 | NCT06050668 | |
| Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer | Atrophy, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, muscular atrophy, neoplasm, nervous system disorder, rectal disorder | Recruiting | Not stated | 2026-10-07 | NCT03998202 | |
| Weaning Assessment by Peripheral Muscle Ultrasonography | Atrophy, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, muscular atrophy, nervous system disorder | Not yet recruiting | Not stated | 2026-10-06 | NCT07860879 | |
| Women in Action: A Multicomponent Intervention for Older Women | Atrophy, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, muscular atrophy, nervous system disorder | Not yet recruiting | Not applicable | 2026-10-06 | NCT07860424 | |
| Taining Golden Lake Comprehensive Chronic Disease Management Initiative | Atrophy, Chronic Disease, Disease Attributes, Dyslipidemias, Frailty, Lipid Metabolism Disorders, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypertensive disorder, metabolic disease, muscular atrophy, nervous system disorder, vascular disorder | Recruiting | Not stated | 2026-10-06 | NCT07308314 | |
| Web-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping Strategies | Head and Neck Neoplasms, Neoplasms by Site, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Spasm, Trismus, neoplasm, nervous system disorder | Recruiting | Phase 2 | 2026-10-06 | NCT04003051 | |
| Low-Volume Pericapsular Nerve Group (PENG) Block With Dexamethasone vs Standard-Volume PENG Block After Total Hip Arthroplasty | Muscle Weakness, Neurologic Manifestations, Neuromuscular Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder | Not yet recruiting | Phase 4 | 2026-10-05 | NCT07855341 | |
| Spinal Mobility, Rigidity, and Kinesiophobia in PD and TMD | Craniomandibular Disorders, Jaw Diseases, Mandibular Diseases, Muscle Hypertonia, Muscle Rigidity, Neurologic Manifestations, Neuromuscular Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Stomatognathic Diseases, arthropathy, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy, temporomandibular joint disorder | Recruiting | Not stated | 2026-10-05 | NCT07850674 | |
| Aprepitant for the Treatment of CLIFAHDD | Channelopathies, Disease Attributes, Dyskinesias, Facies, Muscle Hypotonia, Neurobehavioral Manifestations, Neurologic Manifestations, Neuromuscular Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, atactic disorder, non-human animal, communication disorder, congenital contractures of the limbs and face, hypotonia, and developmental delay, disease, learning disability, nervous system disorder, neurodevelopmental disorder, psychiatric disorder | Recruiting | Early phase 1 | 2026-10-05 | NCT07845825 | |
| Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, Myotonia, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, hereditary disease, inherited neurodegenerative disorder, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myotonic dystrophy, myotonic dystrophy type 1, myotonic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular disease | Recruiting | Phase 3 | 2026-10-05 | NCT07486934 | |
| Sustainable Exercise and Nutrition Programs for Managing Metabolic Disorders in Older Women | Atrophy, Body Weight, Chronic Disease, Disease Attributes, Frailty, Insulin Resistance, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, glucose metabolism disease, hyperinsulinism, metabolic disease, muscular atrophy, nervous system disorder, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Not applicable | 2026-10-05 | NCT07015307 | |
| Effect of Neural Constraints on Movement in Stroke | Muscle Hypertonia, Muscle Spasticity, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Early phase 1 | 2026-10-05 | NCT06666673 | |
| A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Atrophy, Spinal, Type II, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Spinal Muscular Atrophies of Childhood, central nervous system disorder, hereditary disease, inherited neurodegenerative disorder, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proximal spinal muscular atrophy, spinal cord disorder, spinal muscular atrophy, spinal muscular atrophy, type III | Recruiting | Phase 2 | 2026-10-02 | NCT07047144 | |
| GLP-1s to Enhance Lasting Optimal Weight | Atrophy, Body Weight, Body Weight Changes, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, muscular atrophy, nervous system disorder, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 4 | 2026-10-02 | NCT06861439 |